Adamis Pharmaceuticals (ADMP) PT Cut to $10 at Maxim Group as 'Buy' Maintained
Tweet Send to a Friend
Maxim Group analyst Jason Kolbert cut his price target on Adamis Pharmaceuticals (NASDAQ: ADMP) to $10.00 (from $17.00) after adjusting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
